We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Vita Mojo is an award winning food technology company, providing affordable meals tailored specifically to the customer. The food is personal and transparent as to what goes into each dish and how it was prepared. All ingredients are picked to suit your own tastes and needs, and can be personalised to increase your protein or decrease your calories as required. 
days to go: Expired investment: £3,200,080
An award-winning British brewery that combines beer and dinosaurs. Staggeringly Good launched in 2015 and is one of the Top 20 breweries in England as listed by Untappd. The company has grown by 100% YoY, with revenues of £224k by April 2018. In the last 24 months, Staggeringly Good has produced over 250,000 pints in their 11,000L brewery and in the last 12 months, they have served more than 37,000 beers from their taproom. The business is now raising funds to quadruple their brewing capacity to meet growing customer demand. This will be achieved by expanding into the adjacent building, which will also provide a further 10 taprooms. In addition, Staggeringly Good is planning to add their own canning production line and increase their staffing from three full-time employees, as well as further promote their dinsoaur-themed beer festival, WarriorFest.
days to go: Expired investment: £302,810
Launched in October 2016, Big Drop Brewing is a world-leading alcohol-free craft brewer. The company brews beer naturally by using specialist brewing methods to ensure the alcohol never exceeds 0.5%. The beer is not only Alcohol-Free, but is also gluten-free and many are low in sugar.  Their award-winning lager is vegan-friendly. The company does not have a brewery of its own but partners with reputable breweries around the world, who share their brewing values to produce the beer. Big Drop Brewing has secured private funding already and meaningful distribution in the UK and 12 overseas markets. They have also secured off-trade listings in Tesco, Morrisons and Ocado. Half of the investment will be used for Sales & Marketing, 30% for new branding launch and related marketing, 10% for production costs and the remaining 10% for product development.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £617,566
Bioepic is an app which enables users to easily and non-invasively measure their health status in just 30 seconds using just a smartphone. The app calculates pulse wave velocity, body temperature, blood pressure, heart rate variability chaos, vascular stiffness and the effectiveness of inhalers. 
days to go: Expired investment: £12,500
Bird and Blend Tea (BABT) is a British independent tea mixologist. The company claims to offer 100+ blends of tea in a vegan-friendly product range, employs 125+ people and runs a global e-commerce platform attracting 100,000 monthly users. It claims to have achieved a £3.97 million turnover in 2020-2021 despite lockdown closures of its retail stores. BABT asserts that it operates 13 experiential retail stores across the UK since its last crowdfund in 2017. It has also featured in press entities such as The Independent, OK!, Huff Post, The Telegraph, and GQ Magazine. The company states it will use the investment to expedite the growth of its brand with investments in digital innovation, develop its technology stack, strengthen its team, open more multisensory stores, and undertake impactful projects to achieve B Corp status.
days to go: Expired investment: £999,867
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph